VMED — Viromed Medical AG Share Price
Last trade - 00:00- €42.12m
- €41.92m
- 13
- 25
- 31
- 11
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 1,122.96 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.11 | ||
| Price to Tang. Book | 2.11 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -1.78% | ||
| Return on Equity | -0.55% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | n/a | n/a | n/a | n/a | n/a | 4.3 | 7.6 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Viromed Medical AG is a Germany-based company engaged in the supply of medicines. The Company supplies pharma products to clinics, rehabilitation hospitals, nursing homes, medical practitioners, and others. It conducts research on viruses and bacteria along with developing solutions for medical technology such as cold plasma technology used for wound healing, plasma therapy, and produces medical equipment such as ViroCAP, PulmoPlas, used for curative activities such as in the areas of infection protection, dermatology, and intensive care medicine. Its other products and services include nasal sprays, air purifiers, VitaQuiz, corona tests and others.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- August 9th, 2021
- Public Since
- May 4th, 2022
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Dusseldorf Stock Exchange
- Shares in Issue
- 20,250,000
- Address
- Flensburger Strasse 18, PINNEBERG, 25421
- Web
- https://www.viromed-medical-ag.de/
- Phone
- +49 4101809960
- Auditors
- WPU Wirtshaftsprufung Union GmbH
Upcoming Events for VMED
Similar to VMED
Cannovum Cannabis AG
Dusseldorf Stock Exchange
Medios AG
Dusseldorf Stock Exchange
SynBiotic SE
Dusseldorf Stock Exchange
FAQ
As of Today at 24:00 UTC, shares in Viromed Medical AG are trading at €2.00. This share price information is delayed by 15 minutes.
Shares in Viromed Medical AG last closed at €2.00 and the price had moved by +25.79% over the past 365 days. In terms of relative price strength the Viromed Medical AG share price has outperformed the FTSE Global All Cap Index by +9.4% over the past year.
The overall consensus recommendation for Viromed Medical AG is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreViromed Medical AG does not currently pay a dividend.
Viromed Medical AG does not currently pay a dividend.
Viromed Medical AG does not currently pay a dividend.
To buy shares in Viromed Medical AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €2.00, shares in Viromed Medical AG had a market capitalisation of €42.12m.
Here are the trading details for Viromed Medical AG:
- Country of listing: Germany
- Exchange: DUS
- Ticker Symbol: VMED
Based on an overall assessment of its quality, value and momentum Viromed Medical AG is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Viromed Medical AG is €4.60. That is 130% above the last closing price of €2.00.
Analysts covering Viromed Medical AG currently have a consensus Earnings Per Share (EPS) forecast of -€0.02 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Viromed Medical AG. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -47.63%.
As of the last closing price of €2.00, shares in Viromed Medical AG were trading -31.49% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Viromed Medical AG PE ratio based on its reported earnings over the past 12 months is 1122.96. The shares last closed at €2.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Viromed Medical AG's directors